Products - Diabetes | Topic | NICE

Showing 8 products

Date | Title

Status: Topic selectionRemove ‘Status: Topic selection’ filter

Dulaglutide for treating type 2 diabetes in children and young people [TSID10660]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aflibercept for untreated diabetic macular oedema [TSID10621]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Semaglutide for treating type 2 diabetes and associated peripheral arterial disease [TSID11791]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
AI in retinal scanning MT524 (MIB265)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
d-NAV for optimization of personal insulin management in adults with type 2 diabetes (MT696)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740)
Status:
Topic selection
Programme:
Diagnostics guidance
Expected publication date:
TBC
Basal insulin icodec–semaglutide for treating type 2 diabetes inadequately controlled with daily basal insulin [TSID11940]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Orforglipron for treating type 2 diabetes [TSID12130]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC